Trials / Unknown
UnknownNCT04432155
Xenon Inhalation for Treatment of Panic Disorder
A Double-Blind, Randomized, Placebo-Controlled Trial of Xenon Inhalation for Treatment of Patients With Panic Disorder
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Nobilis Therapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a double-blind, randomized, placebo-controlled, clinical trial in parallel groups in patients with panic disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xenon | 30% xenon, 30% oxygen, and 40% nitrogen |
| DRUG | Placebo | 30% oxygen, and 70% nitrogen |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2021-11-01
- Completion
- 2021-12-01
- First posted
- 2020-06-16
- Last updated
- 2021-03-03
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04432155. Inclusion in this directory is not an endorsement.